English Germany Japanese Korean

上海阿拉丁生化科技股份有限公司 公司信息

公司名称: 上海阿拉丁生化科技股份有限公司
电话: 400-6206333
电子邮件:anhua.mao@aladdin-e.com
国籍:中国
网址: www.aladdin-e.com/
产品总数:48457
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

公司提供产品列表

Dehydroepiandrosterone sulfate 651-48-9
8-Azahypoxanthine 8-氮杂次黄嘌呤 2683-90-1
Eculizumab (anti-Complement C5) 219685-50-4
Sirukumab (anti-IL-6) 1194585-53-9
Bimagrumab (anti-ACVR2B) 1356922-05-8
Ulocuplumab (anti-CXCR4) 1375830-34-4
Abelacimab(anti-Factor XI) 2098724-83-3
Tesnatilimab (anti-NKG2D) 2242758-08-1
Zansecimab (anti-ANGPT2) 2415205-37-5
Meropenem-d6 美罗培南-d6 1133424-00-6
Ranibizumab (anti-VEGFA) 347396-82-1
2-(azetidin-1-yl)ethan-1-amine 2-(氮杂环丁烷-1-基)乙-1-胺 795299-77-3
Enoblituzumab (anti-CD276) 1353485-38-7
Flanvotumab (anti-TYRP1) 1188277-05-5
Bermekimab (anti-IL-1a) 1401965-15-8
Inebilizumab (anti-CD19) 1299440-37-1
Prezalumab (anti-B7-H2) 1523164-68-2
Depatuxizumab mafodotin (anti-EGFR) 1585973-65-4
Tinurilimab (anti-CEACAM6) 2226224-30-0
Vandortuzumab (anti-STEAP1) 1557989-52-2
Galiximab (anti-CD80) 357613-77-5
Ethyl 2-oxo-4-phenylbutyrate 2-氧代-4-苯基丁酸乙酯 64920-29-2
Pascolizumab (anti-IL-4) 331243-22-2
Ocrelizumab (anti-CD20) 637334-45-3
Bis(hexamethylene)triamine 双(六甲撑)三胺 143-23-7
Ixekizumab (anti-CTLA-8) 1143503-69-8
Enokizumab (anti-IL-9) 909875-08-7
Concizumab (anti-TFPI) 1312299-39-0
Tarextumab (anti-NOTCH3) 1359940-55-8
Emibetuzumab (anti-MET) 1365287-97-3
Tesidolumab (anti-Complement C5) 1531594-08-7
Xentuzumab (anti-IGF1) 1417158-65-6
Lacnotuzumab (anti-M-CSF) 1831128-32-5
Ladiratuzumab (anti-SLC39A6) 1629760-28-6
Narsoplimab (anti-MASP2) 2108782-45-0
Belimumab (anti-TNFSF13B) 356547-88-1
IDO-IN-13 2291164-02-6
Benzyldiphenylphosphine 苄基二苯基膦 7650-91-1
Alizarin Yellow R sodium salt 茜素黄R钠盐 1718-34-9
Eldelumab (anti-CXCL10) 946414-98-8
Tisotumab (anti-F3) 1418628-81-5
Vopratelimab (anti-ICOS) 2039148-04-2
Ragifilimab (anti-TNFRSF18) 2207590-51-8
Daclizumab (anti-IL2RA) 152923-56-3
Sonepcizumab (anti-Sphingosine-1-phosphate) 1031360-18-5
Rilotumumab (anti-HGF) 872514-65-3
Narnatumab (anti-RON) 1188275-92-4
Carotuximab (anti-CD105) 1268714-50-6
Brazikumab (anti-IL-23) 1610353-18-8
Ontamalimab (anti-MADCAM1) 2098790-40-8
Dostarlimab (anti-PD-1) 2022215-59-2
Avdoralimab (anti-C5AR1) 2226393-85-5
Datopotamab (anti-TROP2) 2267989-53-5
Denintuzumab (anti-CD19) 1630074-14-4
Mogamulizumab (anti-CCR4) 1159266-37-1
Rosmantuzumab (anti-RSPO3) 1684393-04-1
Ianalumab (anti-TNFRSF13C) 1929549-92-7
Quetmolimab (anti-CX3CL1) 2084037-83-0
Gemtuzumab (anti-CD33) 220578-59-6
Telazorlimab (anti-TNFRSF4) 2126777-87-3
Imazapic 甲咪唑烟酸 104098-48-8
Guselkumab (anti-IL-23) 1350289-85-8
Labetuzumab govitecan (anti-CEACAM5) 1469876-18-3
Apamistamab (anti-PTPRC) 2097132-02-8
Sirtratumab (anti-SLITRK6) 1824663-82-2
Nadecnemab (anti-GFRA3) 2377679-19-9
Dysprosium(III) trifluoromethanesulfonate 三氟甲烷磺酸镝 139177-62-1
Efalizumab (anti-ITGAL) 214745-43-4
Elotuzumab (anti-SLAMF7) 915296-00-3
Oxelumab (anti-TNFSF4) 1186098-83-8
Seribantumab (anti-ERBB3) 1334296-12-6
Zagotenemab (anti-Tau) 2019133-28-7
Bexmarilimab (anti-STAB1) 2259301-27-2
Lemzoparlimab (anti-CD47) 2377483-71-9
Enfortumab (anti-NECTIN4) 1448664-46-7
KWAR23 (anti-SIRPg) 2243227-60-1
Lexatumumab (anti-TNFRSF10B) 845816-02-6
Bivatuzumab (anti-CD44v6) 214559-60-1
Urelumab (anti-TNFRSF9) 934823-49-1
Dinutuximab (anti-GD2) 1363687-32-4
Ravulizumab (anti-Complement C5) 1803171-55-2
Apelin 17 TFA Apelin 17 TFA,Apelin受体（APJ）激动剂 217082-57-0
Lumiliximab (anti-FceR2) 357613-86-6
Otilimab (anti-GM-CSF) 1638332-55-4
Fulranumab (anti-NGF) 902141-80-4
Vorsetuzumab (anti-CD70) 1165740-62-4
Vantictumab (anti-FZD) 1345009-45-1
Indusatumab (anti-GUCY2C) 1497400-26-6
Tamrintamab (anti-DPEP3) 2148325-59-9
Cinpanemab (anti-Alpha-synuclein) 2094516-02-4
Daxdilimab (anti-ILT7) 2245966-28-1
Idactamab (anti-SLC1A5) 2245205-37-0
Ponsegromab (anti-GDF15) 2368950-15-4
Gevokizumab (anti-IL-1b) 1129435-60-4
Itolizumab (anti-CD6) 1116433-11-4
Girentuximab (anti-CA9) 916138-87-9
Codrituzumab (anti-GPC3) 1365267-33-9
Vunakizumab (anti-IL-17a) 1792181-33-9
Imaprelimab (anti-CD146) 2014343-04-3
Serplulimab (anti-PDCD1) 2231029-82-4
459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2007© ChemicalBook. All rights reserved.